Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the detailed record of transactions filed by Seelenberger Alexander A., Chief Financial Officer. Officer active across 1 company, notably Vincerx Pharma, Inc.. Aggregated, 5 reports have been published. Split: 5 buys · 0 sell. Total volume traded: €222k. History available since 29 June 2021. The latest transaction was filed on 11 August 2023 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
5 of 5 declarations
Seelenberger Alexander A. is the Chief Financial Officer at Vincerx Pharma, Inc. In this role, he is responsible for the financial management of the company, including budgeting and financial reporting. His expertise in finance is essential to support Vincerx's growth strategy. He plays a key role in developing the company's financial strategies.